Gold status for Vetter: Named Best Managed Company for the fourth time

  • Long-term strategy program propels company into a stable future
  • Pioneer in sustainability along the entire value chain
  • Holistic innovation management established

Ravensburg, 30 May 2023: Vetter, a leading globally operating Contract Development and Manufacturing Organization (CDMO), has been recognized as Best Managed Company for the fourth time in a row – and now carries gold status. The internationally renowned award is presented annually by Deloitte Private, Frankfurter Allgemeine Newspaper and the Federation of German Industries (BDI) to medium-sized and family-run companies in over 40 countries.

“We are very proud to have been awarded this prestigious seal of quality for the fourth time,” says Vetter Managing Director Peter Soelkner. “As a leading service provider in the production of complex injectable drugs, we are an innovative and reliable partner for our large and small customers – especially in economically challenging times. We see this award as a further confirmation that we are on the right track.”

Earning this recognition requires a comprehensive and sustainable strategy. This is Vetter NExT 2029: six initiatives with 26 fields of action and four focus topics worked on by interdisciplinary teams with progress tracked regularly. The entire value chain of the CDMO is strategically covered. Higher-level topics of modern business operations are also addressed, such as digital transformation, organizational development, and sustainability.

Pioneer in sustainability

The judges also set high standards for the sustainability assessment. As one of the leading companies in the highly regulated and energy-intensive biopharma industry, Vetter has already been CO2-neutral worldwide since 2021. Last year, the CDMO published its first comprehensive sustainability report and achieved gold status in the internationally recognized EcoVadis ranking. At the beginning of this year, Vetter joined the UN Global  Compact and is thus driving the expansion of responsible supply chains in the industry and sustainable business processes. The sustainability activities are an integral part of the corporate strategy and cover the areas of economy, ecology, and social issues.

Holistic innovation management for future technologies

An integral part of the corporate strategy is the innovation management process, through which trends are recognized at an early stage and converted into innovations in a targeted manner. The focus lays on sustainable technologies, processes, products, and services. One example is the optimization of production-related processes using new intelligent technologies.

“We continue to develop topic areas in line with customer demands, such as the interaction of man and machine in assistance systems or the use of cooperative and autonomous robots. These initiatives are compelling and at the same time essential in order to offer our customers innovative solutions, and consequently being able to partner at eye level,” explains Vetter Managing Director Thomas Otto. The goal is to continuously improve flexibility, productivity, quality, IT, and operational safety.

Markus Seiz, Program Manager Best Managed Company and Director at Deloitte Private, explains the judge’s assessment as follows: “In all social crises, we look at the resilience and stability of the participating candidates. As a family-owned company, Vetter offers these success factors to a high degree, among others through its forward-looking and holistic strategic planning. In addition, the pharmaceutical service provider is already a leader in key transformation topics such as sustainability. These fields of action ensure future viability, resulting in Vetter being ‘Best in Class’ for us again this year.”

Company: Vetter Pharma-Fertigung GmbH & Co. KG

Vetter is a leading Contract Development and Manufacturing Organization (CDMO) with headquarters in Ravensburg, Germany, and production facilities in Germany, Austria, and the US. As a global player, the pharmaceutical service provider is also present with its own sales locations in the Asia-Pacific markets of Japan, China, South Korea and Singapore. Around the world, small and large renowned pharma and biotech companies rely on the decades of experience, high quality, modern technologies, reliability, and commitment of more than 6,300 employees. In close partnership with its customers, the Vetter team supplies patients all over the world with medicines, many of which are vital. The CDMO provides support from drug product development through clinical and commercial filling to a wide range of assembly and packaging services for vials, syringes, and cartridges. With innovative solutions, Vetter develops prefilled drug-delivery systems together with its customers to continuously improve patient safety, comfort, and compliance. The company is an industry pioneer in sustainability and a socially and ethically responsible corporate citizen. The CDMO is a member of the UN Global Compact and Science Based Target initiative (SBTi) and received platinum status in the renowned EcoVadis ranking. Multiple awards such as the CDMO Leadership Awards, Frost & Sullivan Customer Value Leadership award or the recognition as Best Managed Company emphasize Vetter’s commitment to sustainable business. Founded in Ravensburg in 1950, the company remains family-owned to this day. Learn more about Vetter at

Send Enquiry for this story

By submitting this form you are giving a consent to to store your submitted information.
See our Privacy Policy to learn more about how we use data.